alexa MRSA [Methicillin Resistant Staphylococcus aureus] | Ireland | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

MRSA [Methicillin Resistant Staphylococcus Aureus]

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Pathophysiology: Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. It is also called oxacillin-resistant Staphylococcus aureus. Healthy individuals may carry MRSA asymptomatically for periods ranging from a few weeks to many years. Patients with compromised immune systems are at a significantly greater risk of symptomatic secondary infection.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Statistics: A total of 1,111 residents (66% of all residents) and 553 staff (86% of available staff) in 45 nursing homes participated. The combined prevalence rate of MRSA in the resident population was 23.3% (95% confidence interval (CI)=18.8-27.7%) and 7.5% in staff (95% CI=5.1-9.9%). Residents who lived in nursing homes that were part of a chain were more likely to be colonized with MRSA.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Treatment: Treatment of HA-MRSA frequently involves the use of vancomycin, often in combination with other antibiotics given by IV. CA-MRSA can often be treated on an outpatient basis with specific oral or topical antibiotics, but some serious CA-MRSA infections (for example, pneumonia) often require appropriate antibiotics by IV.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Major Research: Research suggests that certain probiotic strains may help reduce susceptibility to active infection with MRSA. Reduced diversity and strength of the gut microflora leaves us vulnerable to opportunistic infections, while Lactobacillus species such as paracasei, and L. acidophilus, as well as Bifidobacteria animalis subsp lactis have been seen to offer a degree of protection against MRSA.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings